Quest Diagnostics (NYSE: DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory services business. The transaction will expand access to the company's cost-effective and advanced laboratory services in Ohio. The transaction is likely to be completed in the third quarter of 2024, subject to customary regulatory reviews. However, the financial details of the deal were kept under wraps. More on the News Quest Diagnostics' diagnostic insights are derived from one of the world's largest databases of de-identifiable clinical lab results, offering new ways to identify and treat disease, inspire healthy behaviors and enhance healthcare. The latest agreement supports the strategy of growing through accretive outreach lab acquisitions and also broadening its presence across Ohio. Colombia, OH-based OhioHealth is a nationally recognized, not-for-profit, charitable healthcare outreach of the United Methodist Church. Apart from a robust team, it has a network of 15 hospitals, three joint-venture hospitals, one managed-affiliate hospital, more than 200 ambulatory sites and other health services spanning a 50-county area. With this partnership, Quest Diagnostics showcases its ability to attract and collaborate with leading health systems that are seeking to optimize their lab services. Image Source: Zacks Investment Research Following the close of the acquisition, providers and patients will gain access to Quest Diagnostics' industry-leading test menu, a network of patient service sites throughout the state, extensive health plan coverage ...